These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 88105)

  • 21. Organ-specific tolerance induced by intrathymic injection of donor bone marrow cells and FK 506 or antilymphocyte serum in rat heart transplantation.
    Matsuura T; Imanishi M; Hara Y; Tahara H; Kanda H; Kurita T
    Transplant Proc; 1994 Aug; 26(4):1962-3. PubMed ID: 7520616
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of antilymphocyte serum in the induction of immunological tolerance to tissue allografts.
    Monaco AP
    Fed Proc; 1970; 29(1):153-5. PubMed ID: 4904620
    [No Abstract]   [Full Text] [Related]  

  • 23. Specific unresponsiveness to skin allografts in anti-lymphocyte serum-treated, marrow-injected mice: participation of donor marrow-derived suppressor T cells.
    Maki T; Gottschalk R; Wood ML; Monaco AP
    J Immunol; 1981 Oct; 127(4):1433-8. PubMed ID: 6168692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of rapamycin on induction of unresponsiveness in ALS-treated, marrow-injected mice.
    Bobbio SA; Wood ML; Monaco AP
    Transplant Proc; 1993 Feb; 25(1 Pt 1):717-8. PubMed ID: 8438453
    [No Abstract]   [Full Text] [Related]  

  • 25. Unresponsiveness to skin allografts induced by tissue extracts and antilymphocytic serum.
    Brent L; Hansen JA; Kilshaw PJ
    Transplant Proc; 1971 Mar; 3(1):684-7. PubMed ID: 4937959
    [No Abstract]   [Full Text] [Related]  

  • 26. Indirect evidence of two adverse components of the humoral response to skin allografts as revealed in ALS-suppressed mice.
    Nouza K; Hilgert I; Nĕmec M; Kristofová H
    Folia Biol (Praha); 1972; 18(4):264-9. PubMed ID: 4559929
    [No Abstract]   [Full Text] [Related]  

  • 27. Augmentation by donor bone marrow of the survival of neonatal skin transplants to ALS-treated recipients.
    Gozzo JJ; Kowolenko M
    Transplant Proc; 1987 Feb; 19(1 Pt 1):470-1. PubMed ID: 3274809
    [No Abstract]   [Full Text] [Related]  

  • 28. [The feasibility of prolonging the visability of allotransplants by using antilymphocytic and antithrombocytic sera].
    Khundanov LI; Verbitskiĭ MSh; Artsimovich NG; Kipervasser EM; Lagutina NIa
    Probl Gematol Pereliv Krovi; 1972 Feb; 17(2):42-50. PubMed ID: 4558981
    [No Abstract]   [Full Text] [Related]  

  • 29. Induction of unresponsiveness to skin allografts in adult mice disparate at defined regions of the H-2 complex. I. Effect of donor-specific bone marrow in ALS-treated mice.
    Wood ML; Monaco AP
    Transplantation; 1984 Jan; 37(1):35-9. PubMed ID: 6364486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific unresponsiveness to skin allografts in mice. II. The mechanism of unresponsiveness induced by tissue extracts and antilymphocytic serum.
    Kilshaw PJ; Brent L; Thomas AV
    Transplantation; 1974 Jan; 17(1):57-69. PubMed ID: 4148889
    [No Abstract]   [Full Text] [Related]  

  • 31. Hyperacute rejection of skin allografts in the mouse by the administration of alloantibody and rabbit complement.
    Koene RA; Gerlag PG; Hagemann JF; van Haelst UJ; Wijdeveld PG
    J Immunol; 1973 Aug; 111(2):520-6. PubMed ID: 4577882
    [No Abstract]   [Full Text] [Related]  

  • 32. Active enhancement of tissue allografts with antilymphocyte serum and bone marrow.
    Monaco AP; Liegeois A; Wood ML; Clark AW
    Adv Nephrol Necker Hosp; 1975; 5():135-72. PubMed ID: 242206
    [No Abstract]   [Full Text] [Related]  

  • 33. Studies on heterologous antilymphocyte serum in mice. VII. Optimal cellular antigen for induction of immunologic tolerance with antilymphocyte serum.
    Monaco AP; Wood ML
    Transplant Proc; 1970 Dec; 2(4):489-96. PubMed ID: 4939696
    [No Abstract]   [Full Text] [Related]  

  • 34. Properties of anti-dog lymphocytic globulin raised with two cell types and immunization schedules.
    Collste LG; Groth CG; Kashiwagi N; Schantz B; Svehag SE
    Acta Chir Scand; 1972; 138(8):775-80. PubMed ID: 4565722
    [No Abstract]   [Full Text] [Related]  

  • 35. Effectiveness of intrathymic inoculation of soluble antigens in the induction of specific unresponsiveness to rat islet allografts without transient recipient immunosuppression.
    Oluwole SF; Jin MX; Chowdhury NC; Ohajekwe OA
    Transplantation; 1994 Nov; 58(10):1077-81. PubMed ID: 7974714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of phytohemagglutinin and antilymphocyte serum on the survival time of homologous skin grafts in mice].
    Kaden J; Kaden K
    Z Exp Chir; 1973; 6(6):401-9. PubMed ID: 4152194
    [No Abstract]   [Full Text] [Related]  

  • 37. Specific unresponsiveness to skin allografts in mice. 3. Synergistic effect of tissue extracts, Bordetella pertussis, and antilymphocytic serum.
    Pinto M; Brent L; Thomas AV
    Transplantation; 1974 May; 17(5):477-86. PubMed ID: 4363833
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of cyclosporine on the induction of unresponsiveness in antilymphocyte serum-treated, marrow-injected mice.
    Wood ML; Gottschalk R; Monaco AP
    Transplantation; 1988 Sep; 46(3):449-51. PubMed ID: 3047934
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of 6-mercaptopurine-rabbit-anti-mouse lymphocyte globulin on the survival of skin allografts in mice.
    Hilgert I; Malberg K; Matthes K; Ambrosius H
    Folia Biol (Praha); 1982; 28(1):22-7. PubMed ID: 7040118
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunosuppression, virus and oncogenesis in mice.
    Nehlsen SL
    Transplant Proc; 1971 Mar; 3(1):811-3. PubMed ID: 4106340
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.